Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 7Genitourinary 5Thoracic 4Other hematologic neoplasm 3Lymphoid 3Breast 3Gynecologic 2Dermatologic 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other solid neoplasm 1Myeloid 1Head & Neck 1Gastrointestinal 1

Conditions

Stomatitis 1Head and Neck Neoplasms 1

Interventions

Cisplatin 619pembrolizumab 323Radiotherapy 319Cetuximab 274Docetaxel 220Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 74Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 48Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 43tislelizumab 42Standard of Care 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Valacyclovir × Head & Neck × Clear all
NCT07363031 2026-01-23

Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy

Instituto Oncoclinicas

Phase 2 Enrolling by invitation
84 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡